These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27251065)

  • 1. Rho Kinases and Cardiac Remodeling.
    Shimizu T; Liao JK
    Circ J; 2016 Jun; 80(7):1491-8. PubMed ID: 27251065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
    Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
    Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisited and revised: is RhoA always a villain in cardiac pathophysiology?
    Miyamoto S; Del Re DP; Xiang SY; Zhao X; Florholmen G; Brown JH
    J Cardiovasc Transl Res; 2010 Aug; 3(4):330-43. PubMed ID: 20559774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.
    Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L
    J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-kinase in development and heart failure: insights from genetic models.
    Shi J; Zhang L; Wei L
    Pediatr Cardiol; 2011 Mar; 32(3):297-304. PubMed ID: 21327630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small guanine nucleotide-binding protein Rho and myocardial function.
    Ren J; Fang CX
    Acta Pharmacol Sin; 2005 Mar; 26(3):279-85. PubMed ID: 15715922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/- haploinsufficient mice.
    Rikitake Y; Oyama N; Wang CY; Noma K; Satoh M; Kim HH; Liao JK
    Circulation; 2005 Nov; 112(19):2959-65. PubMed ID: 16260635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
    Knipe RS; Tager AM; Liao JK
    Pharmacol Rev; 2015; 67(1):103-17. PubMed ID: 25395505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling.
    Zuo C; Li X; Huang J; Chen D; Ji K; Yang Y; Xu T; Zhu D; Yan C; Gao P
    Cardiovasc Res; 2018 Apr; 114(5):703-712. PubMed ID: 29415171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis.
    Knipe RS; Probst CK; Lagares D; Franklin A; Spinney JJ; Brazee PL; Grasberger P; Zhang L; Black KE; Sakai N; Shea BS; Liao JK; Medoff BD; Tager AM
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):471-481. PubMed ID: 29211497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
    Shi J; Zhang YW; Yang Y; Zhang L; Wei L
    J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different roles of myocardial ROCK1 and ROCK2 in cardiac dysfunction and postcapillary pulmonary hypertension in mice.
    Sunamura S; Satoh K; Kurosawa R; Ohtsuki T; Kikuchi N; Elias-Al-Mamun M; Shimizu T; Ikeda S; Suzuki K; Satoh T; Omura J; Nogi M; Numano K; Siddique MAH; Miyata S; Miura M; Shimokawa H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7129-E7138. PubMed ID: 29987023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of both ROCK1 and ROCK2 genes in cardiomyocytes promotes autophagy and reduces cardiac fibrosis during aging.
    Shi J; Surma M; Yang Y; Wei L
    FASEB J; 2019 Jun; 33(6):7348-7362. PubMed ID: 30848941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting ROCK signaling in health, malignant and non-malignant diseases.
    Shahbazi R; Baradaran B; Khordadmehr M; Safaei S; Baghbanzadeh A; Jigari F; Ezzati H
    Immunol Lett; 2020 Mar; 219():15-26. PubMed ID: 31904392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
    Yan X; Jiao K; Song X
    J Cell Biochem; 2019 Mar; 120(3):3038-3045. PubMed ID: 30474257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease.
    Hartmann S; Ridley AJ; Lutz S
    Front Pharmacol; 2015; 6():276. PubMed ID: 26635606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho kinase (ROCK) inhibitors.
    Liao JK; Seto M; Noma K
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):17-24. PubMed ID: 17666911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
    Shimokawa H; Satoh K
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.